Angiotensin-converting enzyme inhibition decreases growth factor expression in the neonatal rat kidney

Kee Hwan Yoo, Jennifer T. Wolstenholme, Robert L. Chevalier

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The renin-angiotensin system plays an important role in renal growth and development: exposure of the fetus or neonate to angiotensin-converting enzyme (ACE) inhibitors increases mortality and results in growth retardation and abnormal renal development. This study was designed to investigate the effects of ACE inhibition in the neonatal rat on the expression of genes known to modulate renal cellular proliferation, cell interactions, and extracellular matrix. Newborn rat pups were treated with enalapril (30 mg/kg/d) or vehicle for 14 d, and kidneys were removed for Northern analysis of mRNA for transforming growth factor-β1 (TGF-β1), prepro epidermal growth factor (EGF), clusterin, and renin. Distribution of TGF-β1, EGF, and clusterin was also determined by immunohistochemistry. Enalapril treatment resulted in 40% mortality by d 14, reduced body and kidney weight, decreased glomerular area, and caused tubular dilatation (p < 0.05 versus vehicle group). Enalapril decreased renal TGF-β1 and EGF mRNA expression, and increased renal clusterin and renin expression (p < 0.05). Renal tubular immunoreactive EGF was decreased, and clusterin was increased by enalapril treatment. These results indicate that ACE inhibition in the developing kidney reduces the renal expression of critical growth factors, which may account for renal growth impairment. Clusterin expression may increase either due to blockade of tonic angiotensin-mediated inhibition, or as an adaptive response to renal ischemia.

Original languageEnglish
Pages (from-to)588-592
Number of pages5
JournalPediatric Research
Volume42
Issue number5
DOIs
Publication statusPublished - 1997 Jan 1

Fingerprint

Peptidyl-Dipeptidase A
Intercellular Signaling Peptides and Proteins
Kidney
Clusterin
Enalapril
Epidermal Growth Factor
Transforming Growth Factors
Renin
Messenger RNA
Mortality
Angiotensins
Renin-Angiotensin System
Growth
Growth and Development
Angiotensin-Converting Enzyme Inhibitors
Cell Communication
Extracellular Matrix
Dilatation
Fetus
Ischemia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Angiotensin-converting enzyme inhibition decreases growth factor expression in the neonatal rat kidney. / Yoo, Kee Hwan; Wolstenholme, Jennifer T.; Chevalier, Robert L.

In: Pediatric Research, Vol. 42, No. 5, 01.01.1997, p. 588-592.

Research output: Contribution to journalArticle

Yoo, Kee Hwan ; Wolstenholme, Jennifer T. ; Chevalier, Robert L. / Angiotensin-converting enzyme inhibition decreases growth factor expression in the neonatal rat kidney. In: Pediatric Research. 1997 ; Vol. 42, No. 5. pp. 588-592.
@article{646db6e9b10046be8702daf9022801dc,
title = "Angiotensin-converting enzyme inhibition decreases growth factor expression in the neonatal rat kidney",
abstract = "The renin-angiotensin system plays an important role in renal growth and development: exposure of the fetus or neonate to angiotensin-converting enzyme (ACE) inhibitors increases mortality and results in growth retardation and abnormal renal development. This study was designed to investigate the effects of ACE inhibition in the neonatal rat on the expression of genes known to modulate renal cellular proliferation, cell interactions, and extracellular matrix. Newborn rat pups were treated with enalapril (30 mg/kg/d) or vehicle for 14 d, and kidneys were removed for Northern analysis of mRNA for transforming growth factor-β1 (TGF-β1), prepro epidermal growth factor (EGF), clusterin, and renin. Distribution of TGF-β1, EGF, and clusterin was also determined by immunohistochemistry. Enalapril treatment resulted in 40{\%} mortality by d 14, reduced body and kidney weight, decreased glomerular area, and caused tubular dilatation (p < 0.05 versus vehicle group). Enalapril decreased renal TGF-β1 and EGF mRNA expression, and increased renal clusterin and renin expression (p < 0.05). Renal tubular immunoreactive EGF was decreased, and clusterin was increased by enalapril treatment. These results indicate that ACE inhibition in the developing kidney reduces the renal expression of critical growth factors, which may account for renal growth impairment. Clusterin expression may increase either due to blockade of tonic angiotensin-mediated inhibition, or as an adaptive response to renal ischemia.",
author = "Yoo, {Kee Hwan} and Wolstenholme, {Jennifer T.} and Chevalier, {Robert L.}",
year = "1997",
month = "1",
day = "1",
doi = "10.1203/00006450-199711000-00006",
language = "English",
volume = "42",
pages = "588--592",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Angiotensin-converting enzyme inhibition decreases growth factor expression in the neonatal rat kidney

AU - Yoo, Kee Hwan

AU - Wolstenholme, Jennifer T.

AU - Chevalier, Robert L.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - The renin-angiotensin system plays an important role in renal growth and development: exposure of the fetus or neonate to angiotensin-converting enzyme (ACE) inhibitors increases mortality and results in growth retardation and abnormal renal development. This study was designed to investigate the effects of ACE inhibition in the neonatal rat on the expression of genes known to modulate renal cellular proliferation, cell interactions, and extracellular matrix. Newborn rat pups were treated with enalapril (30 mg/kg/d) or vehicle for 14 d, and kidneys were removed for Northern analysis of mRNA for transforming growth factor-β1 (TGF-β1), prepro epidermal growth factor (EGF), clusterin, and renin. Distribution of TGF-β1, EGF, and clusterin was also determined by immunohistochemistry. Enalapril treatment resulted in 40% mortality by d 14, reduced body and kidney weight, decreased glomerular area, and caused tubular dilatation (p < 0.05 versus vehicle group). Enalapril decreased renal TGF-β1 and EGF mRNA expression, and increased renal clusterin and renin expression (p < 0.05). Renal tubular immunoreactive EGF was decreased, and clusterin was increased by enalapril treatment. These results indicate that ACE inhibition in the developing kidney reduces the renal expression of critical growth factors, which may account for renal growth impairment. Clusterin expression may increase either due to blockade of tonic angiotensin-mediated inhibition, or as an adaptive response to renal ischemia.

AB - The renin-angiotensin system plays an important role in renal growth and development: exposure of the fetus or neonate to angiotensin-converting enzyme (ACE) inhibitors increases mortality and results in growth retardation and abnormal renal development. This study was designed to investigate the effects of ACE inhibition in the neonatal rat on the expression of genes known to modulate renal cellular proliferation, cell interactions, and extracellular matrix. Newborn rat pups were treated with enalapril (30 mg/kg/d) or vehicle for 14 d, and kidneys were removed for Northern analysis of mRNA for transforming growth factor-β1 (TGF-β1), prepro epidermal growth factor (EGF), clusterin, and renin. Distribution of TGF-β1, EGF, and clusterin was also determined by immunohistochemistry. Enalapril treatment resulted in 40% mortality by d 14, reduced body and kidney weight, decreased glomerular area, and caused tubular dilatation (p < 0.05 versus vehicle group). Enalapril decreased renal TGF-β1 and EGF mRNA expression, and increased renal clusterin and renin expression (p < 0.05). Renal tubular immunoreactive EGF was decreased, and clusterin was increased by enalapril treatment. These results indicate that ACE inhibition in the developing kidney reduces the renal expression of critical growth factors, which may account for renal growth impairment. Clusterin expression may increase either due to blockade of tonic angiotensin-mediated inhibition, or as an adaptive response to renal ischemia.

UR - http://www.scopus.com/inward/record.url?scp=0013546182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0013546182&partnerID=8YFLogxK

U2 - 10.1203/00006450-199711000-00006

DO - 10.1203/00006450-199711000-00006

M3 - Article

C2 - 9357928

AN - SCOPUS:0013546182

VL - 42

SP - 588

EP - 592

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 5

ER -